Quantcast

Latest Diabetes management Stories

2014-07-07 12:28:53

Agents That Can Elicit Greater Weight Loss Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that Novo Nordisk's fixed-dose combination (FDC) therapy insulin degludec/liraglutide (Xultophy, formerly known as IDegLira) is set to become the clinical gold-standard among FDCs used to treat patients with type 2 diabetes. The competitive advantages that this...

2014-07-07 12:24:22

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MarketVIEW: diabetes vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/marketview_diabetes_vaccines.html Diabetes is a metabolic disorder where the pancreas produces little or no insulin (Type I) OR cells do not respond appropriately to insulin that is produced (Type II). It is estimated that the global prevalence of diabetes is estimated at over 371 million people, a number...

2014-07-03 12:25:46

NEW YORK, July 3, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on the discovery and development of therapeutic products for diseases such as diabetes. The company's lead product - Afrezza inhalation powder - was recently approved by the FDA as a rapid-acting insulin therapy intended to improve glycemic control in adults with type 1 or type 2 diabetes. MannKind was founded by Al Mann for the purpose of developing inhaled insulin as an...

2014-07-03 11:14:23

Diabetologia A systematic review and meta-analysis of available data published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes. However the authors stress that the strength of the results is weakened when studies with high risk of bias are removed, and thus more high quality...

2014-07-01 23:05:14

The Trenton Health Team has been awarded a grant from the state of New Jersey to develop a citywide Clinical Decision Support (CDS) system to improve outcomes for Trenton residents with diabetes and high blood pressure. The Clinical Decision Support system will allow clinicians to leverage the best information available for decisions about patient care. Trenton, NJ (PRWEB) July 01, 2014 The Trenton Health Team has been awarded a $415,000 grant from the state to develop a clinical...

Insulin May Do More Harm Than Good For Some Patients With Type 2 Diabetes
2014-07-01 03:23:59

University of Michigan Health System Harm to quality of life outweighs benefits of treatment for older patients and those with negative feelings about side effects, burden of medication For patients with type 2 diabetes – especially those over age 50 – the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs, says a new study by the University of Michigan Health System, the VA Ann Arbor Healthcare System, and...

Afrezza Inhalation Powder
2014-06-29 04:56:44

April Flowers for redOrbit.com - Your Universe Online Treatment options for diabetes come in a wide variety, ranging from oral medications to insulin pumps. USA Today reports that a new treatment option has been added to the arsenal, Afrezza Inhalation Powder. This week, the US Food and Drug Administration (FDA) approved the rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus, or Type I diabetes. The FDA estimates that 25.8 million people in...

2014-06-27 23:07:03

The team behind the proven SlimPlate System at Ace Medical Weight Loss Center have today revealed their tips and tricks for dealing with diabetes during the summer months in a new series of ask the experts – and it all comes down to portion control. Rock Hill, SC (PRWEB) June 27, 2014 The team behind the proven SlimPlate System of weight loss have today revealed their tips and tricks for dealing with diabetes during the summer months in a new series of ask the experts – and it all...

2014-06-27 08:26:07

Distribution agreement reached with partner to market the Dario(TM)smart meter in Canada CAESAREA, Israel, June 27, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario((TM)) Diabetes Management Solution, announced today that it has entered into a strategic distribution agreement with AutoControl Medical Inc. (ACM) that grants ACM the exclusive right to distribute the Dario((TM) )Smart Meter, test strips and lancets in Canada. Dario(TM) is a...

2014-06-27 08:25:19

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin glargine product from Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim is the first...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.